ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 501

EULAR Definition of “Arthralgia Suspicious for Progression to Rheumatoid Arthritis” in a Cohort of Patients Included in a Program for Rapid Diagnosis: Role of Ultrasound and Antibodies

Jessica Torres Chichande1, Santiago Ruta 2, Einer Sanchez Prado 3, Alvaro Ruta 1, Sebastian Magri 1, Facundo Salvatori 1 and Rodrigo Garcia Salinas 1, 1Hospital Italiano de La Plata, La plata, Buenos Aires, Argentina, 2Rheumatology Department, Hospital San Martín de La Plata and Rheumatology Unit, Hospital Italiano de La Plata, Argentina., La Plata, Argentina, 3Hospital Italiano de La Plata, La Plata

Meeting: ACR/ARP Annual Meeting 2019

Keywords: anti-CCP antibodies and ultrasonography, Early Rheumatoid Arthritis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: To evaluate the performance of the EULAR definition of arthralgias suspicious for progression to rheumatoid arthritis (RA) in a group of patients admitted to “Reuma-check” ® program with hand arthralgias and to estimate the added value of ultrasound (US) and the determination of antibodies.

Methods: Consecutive patients older than 18 years admitted for predominantly hand arthralgias to “Reuma-check” ® program were included. At baseline, laboratory tests (including ESR, CRP, RF and anti-CCP), US of hands and wrists with power Doppler (PD) technique including 22 joints (bilateral wrist, MCP and PIP) and X-ray of hands and feet were performed. Sociodemographic, clinical and clinimetry data were also collected. EULAR defined characteristics describing arthralgia at risk for RA were recorded: history taking: Joint symptoms of recent onset (duration < 1 year), symptoms located in MCP joints, duration of morning stiffness ≥60 min, most severe symptoms present in the early morning, presence of a first-degree relative with RA; physical examination: difficulty with making a fist, positive squeeze test of MCP joints. Each evaluator (laboratory, images and clinician) was blinded to the data of the other studies. In successive visits, definitive diagnosis of RA according to the ACR/EULAR 2010 criteria was established or not. Only patients with at least 2 visits were included for the final analysis.

Results: A total of 192 patients were included. 74% were women and mean age was 53 years (SD 14.2). Of the 192 patients, 23 (12%, 95% CI: 7-16) were diagnosed with RA at follow-up. Mean of baseline characteristics describing arthralgia at risk for RA was 3.7 (SD 2.2) in patients with final diagnosis of RA vs 2.7 (SD 1.7) in non-RA patients (p= 0.02). The area under the ROC curve for the EULAR defined characteristics describing arthralgia at risk for RA for the final diagnosis of RA was 0.6302, adding US with PD and anti-CCP data, the area under the ROC curve were 0.6845 (p= 0.0009) and 0.6554 (p= 0.02), respectively. Table shows features associated with final diagnosis of RA. In the multivariate regression logistic analysis, the only features associated with a final diagnosis of RA were anti-CCP (OR: 11, CI 95%: 1.6-74.3) and US with PD in at least one joint assessed (OR: 22.1, CI 95%: 3.7-129.5).

Conclusion: The EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis had an acceptable performance to predict the development of RA in patients with arthralgias in our cohort of patients and improves adding information of both US with PD and anti-CCP. 12% of patients (23/192) were diagnosed as RA at follow-up. Anti-CCP and US with PD were the main features associated with final diagnosis of RA.


Disclosure: J. Torres Chichande, None; S. Ruta, None; E. Sanchez Prado, None; A. Ruta, None; S. Magri, None; F. Salvatori, None; R. Garcia Salinas, None.

To cite this abstract in AMA style:

Torres Chichande J, Ruta S, Sanchez Prado E, Ruta A, Magri S, Salvatori F, Garcia Salinas R. EULAR Definition of “Arthralgia Suspicious for Progression to Rheumatoid Arthritis” in a Cohort of Patients Included in a Program for Rapid Diagnosis: Role of Ultrasound and Antibodies [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/eular-definition-of-arthralgia-suspicious-for-progression-to-rheumatoid-arthritis-in-a-cohort-of-patients-included-in-a-program-for-rapid-diagnosis-role-of-ultrasound-and-antibodies/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARP Annual Meeting 2019

ACR Meeting Abstracts - https://acrabstracts.org/abstract/eular-definition-of-arthralgia-suspicious-for-progression-to-rheumatoid-arthritis-in-a-cohort-of-patients-included-in-a-program-for-rapid-diagnosis-role-of-ultrasound-and-antibodies/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology